return to press releases

July 9, 2002

AnVil and Owl Research Group Unveil Partnership Agreement

Life sciences discovery pioneer and leading clinical research investigator network team up for business development and marketing efforts

Burlington, MA and Philadelphia, PA - In the latest of a series of new business development deals, life sciences discovery pioneer AnVil and leading clinical research network Owl Research Group, today announced a wide-ranging partnership that calls for both companies to refer each other's services and expertise to their respective client bases, offering life sciences companies a comprehensive combination of skills, resources and experts to fulfill their scientific objectives.

The agreement calls for Owl to refer AnVil to clients who require high-dimensional analysis, visualization and interpretation of large and multiple data sets. AnVil will refer clients to Owl for clinical research study services, including but not limited to identifying experienced clinical investigators for in- and out-patient studies, "one-stop shopping" for all regulatory affairs, contract and budget negotiations, study management including web-based programs for patient enrollment, training programs and quality assurance. Both companies will also call on each other's expertise and services to fulfill internal requirements and capabilities.

"Together, Owl and AnVil offer a uniquely broad and complementary suite of services to our clients. This partnership is a strong move toward increased integration of capabilities and specialties between two dynamic companies," said Dr. Richard D. Gill, President and CEO of AnVil. "Our mutual objective is to provide a wide spectrum of domain knowledge, a goal we feel this agreement amply demonstrates."

"AnVil's team of experts will be a powerful catalyst and able partner to Owl's growing network of clinical investigators," said Dr. Graham Campbell, Ph.D., President & CEO of Owl. "We're looking forward to providing the pharmaceuticals industry with a matchless combination of clinical research capabilities powered by best business practices for study management using leading edge technologies and methodologies."

About AnVil
AnVil is a pioneering life sciences discovery company that turns data into knowledge. AnVil partners with life sciences, pharmaceutical, biotechnology, and healthcare companies, enabling them to see and interpret multiple data sets in integrated, information-rich views. This approach turns data into decision-quality information, generating informed decisions faster and more accurately. AnVil's combination of scientific perspective, expertise and high-dimensional technology uncovers the limitless possibilities within complex data sets.

AnVil is based in Burlington, Massachusetts. For more information, visit www.anvilinfo.com, or call 1-781-272-1600. E-mail inquiries should be sent to: William Wiegler at wwiegler@anvilinfo.com.

About Owl Research Group, Inc.
Owl Research Group is an investigator owned research network of clinical sites located in California, Northern Delaware, Florida, Maryland, New Jersey, New York, Central and S.E. Pennsylvania, Vermont, Washington D.C. The company was established to provide the pharmaceutical industry with rapid and easy access to experienced and committed investigators in practices with large outpatient populations and selected in-patient populations. The company conducts phase II, III and IV clinical trials in accordance with FDA, GCP and sponsor regulations

The company's research activities are conducted predominantly in Chester, Philadelphia, Reading and Wilmington. Each regional location provides access to an integrated network of family practice and specialty sites for both in-patient and out-patient studies. Investigative sites include freestanding private practices, research centers, hospital based practices and academic medical centers.

Copyright © 2002 AnVil, Inc. All rights reserved.

back to top